ImportRefusal LogoImportRefusal

Jamp Pharma Corp

⚠️ High Risk

FEI: 3007860029 • Boucherville, Quebec • CANADA

FEI

FEI Number

3007860029

📍

Location

Boucherville, Quebec

🇨🇦

Country

CANADA
🏢

Address

1380 Rue Newton, , Boucherville, Quebec, Canada

High Risk

FDA Import Risk Assessment

58.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
1
Unique Violations
5/16/2025
Latest Refusal
8/30/2022
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
71.9×20%
Frequency
11.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
5/16/2025
61NCA83ESCITALOPRAM OXALATE
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/19/2023
61NCE85DULOXETINE HYDROCHLORIDE (ANTI-DEPRESSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/30/2022
60LDY05ASPIRIN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Jamp Pharma Corp's FDA import refusal history?

Jamp Pharma Corp (FEI: 3007860029) has 3 FDA import refusal record(s) in our database, spanning from 8/30/2022 to 5/16/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Jamp Pharma Corp's FEI number is 3007860029.

What types of violations has Jamp Pharma Corp received?

Jamp Pharma Corp has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Jamp Pharma Corp come from?

All FDA import refusal data for Jamp Pharma Corp is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.